438 related articles for article (PubMed ID: 30075248)
21. In vitro and in vivo discrepancy in inducing apoptosis by mesenchymal stromal cells delivering membrane-bound tumor necrosis factor-related apoptosis inducing ligand in osteosarcoma pre-clinical models.
Guiho R; Biteau K; Grisendi G; Chatelais M; Brion R; Taurelle J; Renault S; Heymann D; Dominici M; Redini F
Cytotherapy; 2018 Aug; 20(8):1037-1045. PubMed ID: 30093324
[TBL] [Abstract][Full Text] [Related]
22. PhiC31/PiggyBac modified stromal stem cells: effect of interferon γ and/or tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) on murine melanoma.
Bahrambeigi V; Ahmadi N; Moisyadi S; Urschitz J; Salehi R; Haghjooy Javanmard S
Mol Cancer; 2014 Nov; 13():255. PubMed ID: 25428727
[TBL] [Abstract][Full Text] [Related]
23. Mesenchymal stem cells as a novel carrier for targeted delivery of gene in cancer therapy based on nonviral transfection.
Hu YL; Huang B; Zhang TY; Miao PH; Tang GP; Tabata Y; Gao JQ
Mol Pharm; 2012 Sep; 9(9):2698-709. PubMed ID: 22862421
[TBL] [Abstract][Full Text] [Related]
24. A novel therapeutic approach for inflammatory bowel disease by exosomes derived from human umbilical cord mesenchymal stem cells to repair intestinal barrier via TSG-6.
Yang S; Liang X; Song J; Li C; Liu A; Luo Y; Ma H; Tan Y; Zhang X
Stem Cell Res Ther; 2021 May; 12(1):315. PubMed ID: 34051868
[TBL] [Abstract][Full Text] [Related]
25. Antitumor effects of TRAIL-expressing mesenchymal stromal cells in a mouse xenograft model of human mesothelioma.
Lathrop MJ; Sage EK; Macura SL; Brooks EM; Cruz F; Bonenfant NR; Sokocevic D; MacPherson MB; Beuschel SL; Dunaway CW; Shukla A; Janes SM; Steele C; Mossman BT; Weiss DJ
Cancer Gene Ther; 2015 Jan; 22(1):44-54. PubMed ID: 25525034
[TBL] [Abstract][Full Text] [Related]
26. pIL6-TRAIL-engineered umbilical cord mesenchymal/stromal stem cells are highly cytotoxic for myeloma cells both in vitro and in vivo.
Cafforio P; Viggiano L; Mannavola F; Pellè E; Caporusso C; Maiorano E; Felici C; Silvestris F
Stem Cell Res Ther; 2017 Sep; 8(1):206. PubMed ID: 28962646
[TBL] [Abstract][Full Text] [Related]
27. Mesenchymal stromal cells-derived exosomes alleviate ischemia/reperfusion injury in mouse lung by transporting anti-apoptotic miR-21-5p.
Li JW; Wei L; Han Z; Chen Z
Eur J Pharmacol; 2019 Jun; 852():68-76. PubMed ID: 30682335
[TBL] [Abstract][Full Text] [Related]
28. Eliminating established tumor in nu/nu nude mice by a tumor necrosis factor-alpha-related apoptosis-inducing ligand-armed oncolytic adenovirus.
Dong F; Wang L; Davis JJ; Hu W; Zhang L; Guo W; Teraishi F; Ji L; Fang B
Clin Cancer Res; 2006 Sep; 12(17):5224-30. PubMed ID: 16951242
[TBL] [Abstract][Full Text] [Related]
29. TRAIL-engineered bone marrow-derived mesenchymal stem cells: TRAIL expression and cytotoxic effects on C6 glioma cells.
Tang XJ; Lu JT; Tu HJ; Huang KM; Fu R; Cao G; Huang M; Cheng LH; Dai LJ; Zhang L
Anticancer Res; 2014 Feb; 34(2):729-34. PubMed ID: 24511006
[TBL] [Abstract][Full Text] [Related]
30. In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells.
Ciavarella S; Grisendi G; Dominici M; Tucci M; Brunetti O; Dammacco F; Silvestris F
Br J Haematol; 2012 Jun; 157(5):586-98. PubMed ID: 22420897
[TBL] [Abstract][Full Text] [Related]
31. A therapeutic strategy for metastatic malignant fibrous histiocytoma through mesenchymal stromal cell-mediated TRAIL production.
Lee HJ; Yang HM; Choi YS; Park SH; Moon SH; Lee YS; Sung YC; Kim SJ
Ann Surg; 2013 May; 257(5):952-60. PubMed ID: 23108118
[TBL] [Abstract][Full Text] [Related]
32. Mesenchymal stem cells as natural biofactories for exosomes carrying miR-124a in the treatment of gliomas.
Lang FM; Hossain A; Gumin J; Momin EN; Shimizu Y; Ledbetter D; Shahar T; Yamashita S; Parker Kerrigan B; Fueyo J; Sawaya R; Lang FF
Neuro Oncol; 2018 Feb; 20(3):380-390. PubMed ID: 29016843
[TBL] [Abstract][Full Text] [Related]
33. Growth inhibition of colorectal carcinoma by lentiviral TRAIL-transgenic human mesenchymal stem cells requires their substantial intratumoral presence.
Luetzkendorf J; Mueller LP; Mueller T; Caysa H; Nerger K; Schmoll HJ
J Cell Mol Med; 2010 Sep; 14(9):2292-304. PubMed ID: 19508388
[TBL] [Abstract][Full Text] [Related]
34. Exosomes derived from mesenchymal stem cells enhance radiotherapy-induced cell death in tumor and metastatic tumor foci.
de Araujo Farias V; O'Valle F; Serrano-Saenz S; Anderson P; Andrés E; López-Peñalver J; Tovar I; Nieto A; Santos A; Martín F; Expósito J; Oliver FJ; de Almodóvar JMR
Mol Cancer; 2018 Aug; 17(1):122. PubMed ID: 30111323
[TBL] [Abstract][Full Text] [Related]
35. Site-Specific Integration of TRAIL in iPSC-Derived Mesenchymal Stem Cells for Targeted Cancer Therapy.
Wang Z; Chen H; Wang P; Zhou M; Li G; Hu Z; Hu Q; Zhao J; Liu X; Wu L; Liang D
Stem Cells Transl Med; 2022 Mar; 11(3):297-309. PubMed ID: 35267023
[TBL] [Abstract][Full Text] [Related]
36. The application of mRNA-based gene transfer in mesenchymal stem cell-mediated cytotoxicity of glioma cells.
Guo XR; Yang ZS; Tang XJ; Zou DD; Gui H; Wang XL; Ma SN; Yuan YH; Fang J; Wang B; Zhang L; Sun XY; Warnock GL; Dai LJ; Tu HJ
Oncotarget; 2016 Aug; 7(34):55529-55542. PubMed ID: 27487125
[TBL] [Abstract][Full Text] [Related]
37. Hepatoprotective effect of exosomes from human-induced pluripotent stem cell-derived mesenchymal stromal cells against hepatic ischemia-reperfusion injury in rats.
Nong K; Wang W; Niu X; Hu B; Ma C; Bai Y; Wu B; Wang Y; Ai K
Cytotherapy; 2016 Dec; 18(12):1548-1559. PubMed ID: 27592404
[TBL] [Abstract][Full Text] [Related]
38. Role of Tumor Necrosis Factor-Producing Mesenchymal Stem Cells on Apoptosis of Chronic B-lymphocytic Tumor Cells Resistant to Fludarabine-based Chemotherapy.
Valizadeh A; Ahmadzadeh A; Saki G; Khodadadi A; Teimoori A
Asian Pac J Cancer Prev; 2015; 16(18):8533-9. PubMed ID: 26745113
[TBL] [Abstract][Full Text] [Related]
39. Antitumor Activity of Cabazitaxel and MSC-TRAIL Derived Extracellular Vesicles in Drug-Resistant Oral Squamous Cell Carcinoma.
Qiu Y; Sun J; Qiu J; Chen G; Wang X; Mu Y; Li K; Wang W
Cancer Manag Res; 2020; 12():10809-10820. PubMed ID: 33149686
[TBL] [Abstract][Full Text] [Related]
40. Tumor necrosis factor gene-engineered J558 tumor cell-released exosomes stimulate tumor antigen P1A-specific CD8+ CTL responses and antitumor immunity.
Xie Y; Bai O; Zhang H; Li W; Xiang J
Cancer Biother Radiopharm; 2010 Feb; 25(1):21-8. PubMed ID: 20187793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
